Eden Research plc (LON:EDEN – Get Free Report) was up 2.8% on Tuesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Price Performance
The business has a 50-day moving average of GBX 3.88 and a two-hundred day moving average of GBX 4.01. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The firm has a market cap of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Stories
- Five stocks we like better than Eden Research
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is Insider Trading? What You Can Learn from Insider Trading
- What Does the Future Hold for Eli Lilly?
- Short Selling: How to Short a Stock
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
